|
1
|
Parkin DM: Global cancer statistics in the
year 2000. Lancet Oncol. 2:533–543. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hao K, Luk JM, Lee NP, Mao M, Zhang C,
Ferguson MD, Lamb J, Dai H, Ng IO, Sham PC, et al: Predicting
prognosis in hepatocellular carcinoma after curative surgery with
common clinicopathologic parameters. BMC Cancer. 9:3892009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Drakaki A, Hatziapostolou M and Iliopoulos
D: Therapeutically targeting microRNAs in liver cancer. Curr Pharm
Des. 19:1180–1191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He XX, Chang Y, Meng FY, Wang MY, Xie QH,
Tang F, Li PY, Song YH and Lin JS: MicroRNA-375 targets AEG-1 in
hepatocellular carcinoma and suppresses liver cancer cell growth in
vitro and in vivo. Oncogene. 31:3357–3369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang L, Wong CM, Ying Q, Fan DN, Huang S,
Ding J, Yao J, Yan M, Li J, Yao M, et al: MicroRNA-125b
suppressesed human liver cancer cell proliferation and metastasis
by directly targeting oncogene LIN28B2. Hepatology.
52:1731–1740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang S and He X: The role of microRNAs in
liver cancer progression. Br J Cancer. 104:235–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chitwood DH and Timmermans MC: Small RNAs
are on the move. Nature. 467:415–419. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kosik KS: MicroRNAs and cellular
phenotypy. Cell. 143:21–26. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hui AB, Shi W, Boutros PC, Miller N,
Pintilie M, Fyles T, McCready D, Wong D, Gerster K, Waldron L, et
al: Robust global micro-RNA profiling with formalin-fixed
paraffin-embedded breast cancer tissues. Lab Invest. 89:597–606.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen
XM and Gao HJ: Initial study of microRNA expression profiles of
colonic cancer without lymph node metastasis. J Dig Dis. 11:50–54.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun M, Liu XH, Li JH, Yang JS, Zhang EB,
Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: MiR-196a is
upregulated in gastric cancer and promotes cell proliferation by
downregulating p27 (kip1). Mol Cancer Ther. 11:842–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang R, Wang ZX, Yang JS, Pan X, De W and
Chen LB: MicroRNA-451 functions as a tumor suppressor in human
non-small cell lung cancer by targeting ras-related protein 14
(RAB14). Oncogene. 30:2644–2658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Braig S, Mueller DW, Rothhammer T and
Bosserhoff AK: MicroRNA miR-196a is a central regulator of HOX-B7
and BMP4 expression in malignant melanoma. Cell Mol Life Sci.
67:3535–3548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guan Y, Mizoguchi M, Yoshimoto K, Hata N,
Shono T, Suzuki SO, Araki Y, Kuga D, Nakamizo A, Amano T, et al:
MiRNA-196 is upregulated in glioblastoma but not in anaplastic
astrocytoma and has prognostic significance. Clin Cancer Res.
16:4289–4297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schimanski CC, Frerichs K, Rahman F,
Berger M, Lang H, Galle PR, Moehler M and Gockel I: High
miR-196a levels promote the oncogenic phenotype of
colorectal cancer cells. World J Gastroenterol. 15:2089–2096. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du Y, Zhu M, Zhou X, Huang Z, Zhu J, Xu J,
Cheng G, Shu Y, Liu P, Zhu W, et al: MiR-20a enhances cisplatin
resistance of human gastric cancer cell line by targeting NFKBIB.
Tumour Biol. 20:1–9. 2015.
|
|
20
|
Huang F, Tang J, Zhuang X, Zhuang Y, Cheng
W, Chen W, Yao H and Zhang S: MiR-196a promotes pancreatic cancer
progression by targeting nuclear factor kappa-B-inhibitor alpha.
PLoS One. 9:e878972014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou T, Ou J, Zhao X, Huang X, Huang Y and
Zhang Y: MicroRNA-196a promotes cervical cancer proliferation
through the regulation of FOXO1 and p27Kip1. Br J
Cancer. 110:1260–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Zheng F, Yu G, Yin Y and Lu Q:
miR-196a targets netrin 4 and regulates cell proliferation and
migration of cervical cancer cells. Biochem Biophys Res Commun.
440:582–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu M, Du Y, Gao J, Liu J, Kong X, Gong Y,
Li Z, Wu H and Chen H: Aberrant expression miR-196a is associated
with abnormal apoptosis, invasion, and proliferation of pancreatic
cancer cells. Pancreas. 42:1169–1181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Y, Wang Y and Zhu WG: Applications of
post-translational modifications of FoxO family proteins in
biological functions. J Mol Cell Biol. 3:276–282. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Gan B, Liu D and Paik JH: FoxO
family members in cancer. Cancer Biol Ther. 12:253–259. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carbajo-Pescador S, Mauriz JL,
García-Palomo A and González-Gallego J: FoxO proteins: Regulation
and molecular targets in liver cancer. Curr Med Chem. 21:1231–1246.
2014. View Article : Google Scholar : PubMed/NCBI
|
